Connection

Donald Dipette to Blood Pressure

Back to Details
This is a "connection" page, showing publications Donald Dipette has written about Blood Pressure.
Donald Dipette
Connection Strength
3.023
Blood Pressure
  1. Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications. J Clin Hypertens (Greenwich). 2019 01; 21(1):4-15.
    View in: PubMed
    Score: 0.432
  2. Resistant Hypertension: Is There a Pathophysiologic Role for the Metalloproteinase System? J Clin Hypertens (Greenwich). 2016 10; 18(10):966-968.
    View in: PubMed
    Score: 0.367
  3. Calcitonin gene-related peptide and substance P contribute to reduced blood pressure in sympathectomized rats. Am J Physiol Heart Circ Physiol. 2005 Sep; 289(3):H1169-75.
    View in: PubMed
    Score: 0.169
  4. Inadequate hypertension control rates: A global concern for countries of all income levels. J Clin Hypertens (Greenwich). 2022 03; 24(3):362-364.
    View in: PubMed
    Score: 0.135
  5. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension. 2022 01; 79(1):293-301.
    View in: PubMed
    Score: 0.133
  6. Self-measurement of blood pressure in the workplace: An expansion of out-of-office blood pressure measurements to unmask masked hypertension. J Clin Hypertens (Greenwich). 2021 02; 23(2):215-217.
    View in: PubMed
    Score: 0.125
  7. Determining central blood pressure: Role in the prediction of the decline of renal function. J Clin Hypertens (Greenwich). 2020 02; 22(2):243-244.
    View in: PubMed
    Score: 0.117
  8. The Accuracy in Measurement of Blood Pressure (AIM-BP) collaborative: Background and rationale. J Clin Hypertens (Greenwich). 2019 12; 21(12):1780-1783.
    View in: PubMed
    Score: 0.116
  9. Editorial commentary: Two years post the ACC/AHA 2017 hypertension guidelines: Where are we now? Trends Cardiovasc Med. 2020 04; 30(3):165-167.
    View in: PubMed
    Score: 0.113
  10. Genetics of hypertension: Implications of single nucleotide polymorphism(s) in African populations and beyond. J Clin Hypertens (Greenwich). 2018 03; 20(3):496-498.
    View in: PubMed
    Score: 0.103
  11. Calcitonin gene-related peptide is a depressor in subtotal nephrectomy hypertension. Hypertension. 1998 Jan; 31(1 Pt 2):391-6.
    View in: PubMed
    Score: 0.102
  12. Relationship between homocysteine and hypertension: New data add to the debate. J Clin Hypertens (Greenwich). 2017 11; 19(11):1171-1172.
    View in: PubMed
    Score: 0.100
  13. Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels. J Clin Hypertens (Greenwich). 2017 May; 19(5):456-461.
    View in: PubMed
    Score: 0.096
  14. Regulation of neuronal calcitonin gene-related peptide expression. Role of increased blood pressure. Hypertension. 1995 Dec; 26(6 Pt 2):1177-80.
    View in: PubMed
    Score: 0.088
  15. Top 10 landmark studies in hypertension. J Am Soc Hypertens. 2014 Jun; 8(6):437-47.
    View in: PubMed
    Score: 0.078
  16. Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol. 1993 Sep; 265(3 Pt 1):E362-6.
    View in: PubMed
    Score: 0.075
  17. Vascular reactivity to calcitonin gene-related peptide is enhanced in subtotal nephrectomy-salt induced hypertension. Am J Physiol Heart Circ Physiol. 2011 Sep; 301(3):H683-8.
    View in: PubMed
    Score: 0.064
  18. Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension. J Hypertens. 1990 Jun; 8(6):515-20.
    View in: PubMed
    Score: 0.060
  19. Compensatory pressor role of vasopressin following acute diuresis. J Hypertens. 1988 Aug; 6(8):633-8.
    View in: PubMed
    Score: 0.053
  20. Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage. Hypertension. 2005 Jan; 45(1):109-14.
    View in: PubMed
    Score: 0.041
  21. Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res. 2002 Sep; 35(9):1033-45.
    View in: PubMed
    Score: 0.035
  22. Substance P in subtotal nephrectomy-salt hypertension. Hypertension. 2002 Feb; 39(2 Pt 2):389-93.
    View in: PubMed
    Score: 0.034
  23. Role of calcitonin gene-related peptide and substance P in Dahl-salt hypertension. Hypertension. 2001 Sep; 38(3 Pt 2):679-82.
    View in: PubMed
    Score: 0.033
  24. Omapatrilat in subtotal nephrectomy-salt hypertension: role of calcitonin gene-related peptide. Hypertension. 2001 Sep; 38(3 Pt 2):697-700.
    View in: PubMed
    Score: 0.033
  25. Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat. Hypertension. 2001 Feb; 37(2 Pt 2):728-32.
    View in: PubMed
    Score: 0.031
  26. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension. 2000 Jan; 35(1 Pt 2):470-5.
    View in: PubMed
    Score: 0.029
  27. Differences in the response to periarterial nerve stimulation or exogenous noradrenaline infusion in the mesenteric vascular bed with the intestinal tract harvested from commonly used rat models of hypertension. Clin Exp Pharmacol Physiol. 2019 05; 46(5):427-434.
    View in: PubMed
    Score: 0.027
  28. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension. 1997 Apr; 29(4):945-50.
    View in: PubMed
    Score: 0.024
  29. Regulation of angiotensin type 1 receptor and its gene expression: role in renal growth. J Am Soc Nephrol. 1997 Feb; 8(2):193-8.
    View in: PubMed
    Score: 0.024
  30. Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project. J Clin Hypertens (Greenwich). 2016 12; 18(12):1284-1294.
    View in: PubMed
    Score: 0.023
  31. Case report: stimulation of severe hypertension as a means of malingering. Am J Med Sci. 1992 Oct; 304(4):258-60.
    View in: PubMed
    Score: 0.018
  32. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension. 1992 Feb; 19(2 Suppl):II105-10.
    View in: PubMed
    Score: 0.017
  33. Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide. Am J Med Sci. 1989 Feb; 297(2):65-70.
    View in: PubMed
    Score: 0.014
  34. Systemic and regional hemodynamic effects of dietary calcium supplementation in mineralocorticoid hypertension. Hypertension. 1989 Jan; 13(1):77-82.
    View in: PubMed
    Score: 0.014
  35. Haemodynamic response to magnesium administration in mineralocorticoid-salt and two-kidney, one clip renovascular hypertension. J Hypertens. 1988 May; 6(5):413-7.
    View in: PubMed
    Score: 0.013
  36. Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2008 Mar; 294(3):H1291-7.
    View in: PubMed
    Score: 0.013
  37. Clinical use of 24-hour ambulatory blood pressure monitoring. Nurse Pract. 1987 Feb; 12(2):30, 34-40, 45-6.
    View in: PubMed
    Score: 0.012
  38. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension. 2005 Jul; 46(1):51-7.
    View in: PubMed
    Score: 0.011
  39. Activation of the renin-angiotensin system in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. J Hypertens. 2004 Jul; 22(7):1345-9.
    View in: PubMed
    Score: 0.010
  40. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod. 2001 Jun; 64(6):1776-83.
    View in: PubMed
    Score: 0.008
  41. Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy. Hypertension. 1997 Jan; 29(1 Pt 2):248-53.
    View in: PubMed
    Score: 0.006
  42. Regulation of growth of the adrenal gland in DOC-salt hypertension. Role of angiotensin II receptor subtypes. Hypertension. 1997 Jan; 29(1 Pt 2):408-13.
    View in: PubMed
    Score: 0.006
  43. Decreased spinal cord content of calcitonin gene-related peptide in the spontaneously hypertensive rat. Neurosci Lett. 1991 Oct 14; 131(2):183-6.
    View in: PubMed
    Score: 0.004
  44. Renin profile, race, and antihypertensive efficacy with atenolol and labetalol. J Hum Hypertens. 1991 Jun; 5(3):193-8.
    View in: PubMed
    Score: 0.004
  45. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther. 1991 Jan; 256(1):110-8.
    View in: PubMed
    Score: 0.004
  46. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients. Clin Pharmacol Ther. 1990 Dec; 48(6):665-75.
    View in: PubMed
    Score: 0.004
  47. Effects of calcium channel blockade on calcium homeostasis in mild to moderate essential hypertension. Am J Med Sci. 1990 Sep; 300(3):133-7.
    View in: PubMed
    Score: 0.004
  48. Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart. Life Sci. 1987 Aug 03; 41(5):597-603.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.